[Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of Canadian psychiatry].
Stip
E
E
Département de Psychiatrie, Université de Montréal.
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001291:Attitude of Health Personnel; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D019317:Evidence-Based Medicine; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence; D007273:Injections, Intramuscular; D011569:Psychiatric Status Rating Scales; D017010:Reminder Systems; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D055502:Secondary Prevention; D016896:Treatment Outcome; D016312:Treatment Refusal / Q000331:legislation & jurisprudence / Q000523:psychology
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations